§ 13F · FUND PROFILE
Bellevue Group AG.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 167Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$315M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC | 667K | $298M | 7.1% | ±0% |
| 2 | ARGX | ARGENX SE | 313K | $229M | 5.4% | −32% |
| 3 | REGN | REGENERON PHARMACEUTICALS | 277K | $214M | 5.1% | +1901% |
| 4 | SRRK | SCHOLAR ROCK HLDG CORP | 3.58M | $176M | 4.2% | −12% |
| 5 | GILD | GILEAD SCIENCES INC | 1.12M | $156M | 3.7% | +2118% |
| 6 | RVMD | REVOLUTION MEDICINES INC | 1.54M | $150M | 3.6% | −69% |
| 7 | IONS | IONIS PHARMACEUTICALS INC | 1.79M | $134M | 3.2% | −62% |
| 8 | ISRG | INTUITIVE SURGICAL INC | 287K | $132M | 3.1% | −11% |
| 9 | VRDN | VIRIDIAN THERAPEUTICS INC | 6.72M | $131M | 3.1% | +54% |
| 10 | KRYS | KRYSTAL BIOTECH INC | 480K | $124M | 3.0% | +17% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE BELLEVUE SIGNAL
AC read
Bellevue Group AG is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed